166 related articles for article (PubMed ID: 25476790)
1. The effect of UGTs polymorphism on the auto-induction phase II metabolism-mediated pharmacokinetics of dihydroartemisinin in healthy Chinese subjects after oral administration of a fixed combination of dihydroartemisinin-piperaquine.
Zang M; Zhu F; Zhao L; Yang A; Li X; Liu H; Xing J
Malar J; 2014 Dec; 13():478. PubMed ID: 25476790
[TBL] [Abstract][Full Text] [Related]
2. Auto-induction of phase I and phase II metabolism of artemisinin in healthy Chinese subjects after oral administration of a new artemisinin-piperaquine fixed combination.
Zang M; Zhu F; Li X; Yang A; Xing J
Malar J; 2014 Jun; 13():214. PubMed ID: 24889062
[TBL] [Abstract][Full Text] [Related]
3. An investigation of the auto-induction of and gender-related variability in the pharmacokinetics of dihydroartemisinin in the rat.
Zhu F; Du F; Li X; Xing J
Malar J; 2012 Nov; 11():379. PubMed ID: 23171067
[TBL] [Abstract][Full Text] [Related]
4. The multiple-dosing pharmacokinetics of artemether, artesunate, and their metabolite dihydroartemisinin in rats.
Xing J; Bai KH; Liu T; Wang RL; Zhang LF; Zhang SQ
Xenobiotica; 2011 Mar; 41(3):252-8. PubMed ID: 21175296
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of dihydroartemisinin in Artekin tablets for single and repeated dosing in Chinese healthy volunteers.
Hong X; Liu CH; Huang XT; Huang TL; Ye SM; Ou WP; Wang NS; Mi SQ
Biopharm Drug Dispos; 2008 May; 29(4):237-44. PubMed ID: 18350560
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects.
Tan B; Naik H; Jang IJ; Yu KS; Kirsch LE; Shin CS; Craft JC; Fleckenstein L
Malar J; 2009 Dec; 8():304. PubMed ID: 20021657
[TBL] [Abstract][Full Text] [Related]
7. Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers.
Fortin A; Verbeeck RK; Jansen FH
Eur J Clin Pharmacol; 2011 Mar; 67(3):267-75. PubMed ID: 20949263
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
Zongo I; Somé FA; Somda SA; Parikh S; Rouamba N; Rosenthal PJ; Tarning J; Lindegardh N; Nosten F; Ouédraogo JB
PLoS One; 2014; 9(8):e103200. PubMed ID: 25133389
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
Tarning J; Kloprogge F; Piola P; Dhorda M; Muwanga S; Turyakira E; Nuengchamnong N; Nosten F; Day NP; White NJ; Guerin PJ; Lindegardh N
Malar J; 2012 Aug; 11():293. PubMed ID: 22913677
[TBL] [Abstract][Full Text] [Related]
10. Effect of coadministered fat on the tolerability, safety, and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria.
Moore BR; Benjamin JM; Salman S; Griffin S; Ginny E; Page-Sharp M; Robinson LJ; Siba P; Batty KT; Mueller I; Davis TM
Antimicrob Agents Chemother; 2014 Oct; 58(10):5784-94. PubMed ID: 25049242
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine.
Ali S; Najmi MH; Tarning J; Lindegardh N
Malar J; 2010 Oct; 9():275. PubMed ID: 20932349
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
Dama S; Niangaly H; Djimde M; Sagara I; Guindo CO; Zeguime A; Dara A; Djimde AA; Doumbo OK
Malar J; 2018 Oct; 17(1):347. PubMed ID: 30290808
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria.
Morris CA; Onyamboko MA; Capparelli E; Koch MA; Atibu J; Lokomba V; Douoguih M; Hemingway-Foday J; Wesche D; Ryder RW; Bose C; Wright L; Tshefu AK; Meshnick S; Fleckenstein L
Malar J; 2011 May; 10():114. PubMed ID: 21548983
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.
Benjamin JM; Moore BR; Salman S; Page-Sharp M; Tawat S; Yadi G; Lorry L; Siba PM; Batty KT; Robinson LJ; Mueller I; Davis TM
Antimicrob Agents Chemother; 2015 Jul; 59(7):4260-71. PubMed ID: 25963981
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine.
Permala J; Tarning J; Nosten F; White NJ; Karlsson MO; Bergstrand M
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242661
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers.
Chotsiri P; Wattanakul T; Hoglund RM; Hanboonkunupakarn B; Pukrittayakamee S; Blessborn D; Jittamala P; White NJ; Day NPJ; Tarning J
Br J Clin Pharmacol; 2017 Dec; 83(12):2752-2766. PubMed ID: 28695570
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study.
Li Q; Remich S; Miller SR; Ogutu B; Otieno W; Melendez V; Teja-Isavadharm P; Weina PJ; Hickman MR; Smith B; Polhemus M
Malar J; 2014 Jul; 13():281. PubMed ID: 25047305
[TBL] [Abstract][Full Text] [Related]
18. Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children.
Sundell K; Jagannathan P; Huang L; Bigira V; Kapisi J; Kakuru MM; Savic R; Kamya MR; Dorsey G; Aweeka F
Malar J; 2015 Sep; 14():368. PubMed ID: 26403465
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.
Simpson JA; Agbenyega T; Barnes KI; Di Perri G; Folb P; Gomes M; Krishna S; Krudsood S; Looareesuwan S; Mansor S; McIlleron H; Miller R; Molyneux M; Mwenechanya J; Navaratnam V; Nosten F; Olliaro P; Pang L; Ribeiro I; Tembo M; van Vugt M; Ward S; Weerasuriya K; Win K; White NJ
PLoS Med; 2006 Nov; 3(11):e444. PubMed ID: 17132053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]